BioLargo, Inc. (BLGO)
USD 0.18
(-2.7%)
USD 0.18
(-2.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.23 Million | 5.88 Million | 2.53 Million | 2.43 Million | 1.86 Million | 1.36 Million |
| Cost of Revenue | 6.07 Million | 3.02 Million | 1.42 Million | 1.2 Million | 945 Thousand | 743 Thousand |
| Gross Profit | 6.15 Million | 2.85 Million | 1.1 Million | 1.22 Million | 916 Thousand | 621 Thousand |
| Operating Expenses | 10.34 Million | 7.97 Million | 7.48 Million | 8.67 Million | 7.39 Million | 6.87 Million |
| Selling, General and Administrative Expenses | 8.05 Million | 6.73 Million | 6.17 Million | 7.47 Million | 6.14 Million | 5.26 Million |
| Research and Development Expenses | 2.28 Million | 1.31 Million | 1.36 Million | 1.33 Million | 1.47 Million | 1.71 Million |
| Other Expenses | - | -74 Thousand | -55 Thousand | -137 Thousand | -218 Thousand | 73 Thousand |
| Cost and Expenses | 16.41 Million | 11 Million | 8.91 Million | 9.87 Million | 8.33 Million | 7.61 Million |
| Operating Income | -4.18 Million | -5.11 Million | -6.38 Million | -7.44 Million | -6.47 Million | -6.41 Million |
| Interest Expense | 91 Thousand | 53 Thousand | 234 Thousand | 1.92 Million | 3.99 Million | 3.49 Million |
| Income Tax Expense | 13 Thousand | -636 Thousand | 483 Thousand | 766 Thousand | 3.3 Million | -790 Thousand |
| Earnings before Tax | -4.63 Million | -5.13 Million | -6.89 Million | -9.7 Million | -11.44 Million | -10.69 Million |
| Net Income | -3.5 Million | -4.49 Million | -7.37 Million | -10.46 Million | -14.74 Million | -10.22 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.03 | -0.05 | -0.10 | -0.08 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.03 | -0.05 | -0.10 | -0.08 |
| Weighted Average Shares Outstanding | 285.95 Million | 268.3 Million | 247.2 Million | 195.99 Million | 152.08 Million | 122 Million |
| Weighted Average Shares Outstanding (Diluted) | 285.95 Million | 268.3 Million | 247.2 Million | 195.99 Million | 152.08 Million | 122 Million |
| Gross Margin | 0.50 | 0.49 | 0.44 | 0.50 | 0.49 | 0.46 |
| EBIT Margin | -0.34 | -0.85 | -2.49 | -2.99 | -3.41 | -4.49 |
| Profit Margin | -0.29 | -0.76 | -2.91 | -4.30 | -7.93 | -7.49 |
| EBITDA | -4.18 Million | -5.09 Million | -6.7 Million | -7.83 Million | -7.44 Million | -7.22 Million |
| Earnings Before Tax Margin | -0.34 | -0.87 | -2.52 | -3.06 | -3.48 | -4.70 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.01 Million | 4.76 Million | 12.23 Million | 4.37 Million | 2.67 Million | 1.44 Million |
| Cost of Revenue | 2.87 Million | 2.51 Million | 6.07 Million | 2.28 Million | 1.23 Million | 627 Thousand |
| Gross Profit | 2.13 Million | 2.24 Million | 6.15 Million | 2.08 Million | 1.43 Million | 819 Thousand |
| Operating Expenses | 3.02 Million | 3 Million | 10.34 Million | 2.67 Million | 2.97 Million | 2.37 Million |
| Selling, General and Administrative Expenses | 2.4 Million | 2.22 Million | - | 2.26 Million | 2.27 Million | 1.79 Million |
| Research and Development Expenses | 623 Thousand | 784 Thousand | - | 408 Thousand | 694 Thousand | 587 Thousand |
| Other Expenses | -15 Thousand | - | - | -1.33 Million | - | -55 Thousand |
| Cost and Expenses | 5.9 Million | 5.52 Million | 16.41 Million | 4.95 Million | 4.2 Million | 3 Million |
| Operating Income | -890 Thousand | -763 Thousand | -4.18 Million | -584 Thousand | -1.53 Million | -1.55 Million |
| Interest Expense | 2000.00 | 12 Thousand | -91 Thousand | 19 Thousand | -12 Thousand | 12 Thousand |
| Income Tax Expense | -339 Thousand | -365 Thousand | 13 Thousand | 27 Thousand | -76 Thousand | -341 Thousand |
| Earnings before Tax | -780 Thousand | -775 Thousand | -4.63 Million | -993 Thousand | -1.2 Million | -1.62 Million |
| Net Income | -441 Thousand | -410 Thousand | -3.5 Million | -729 Thousand | -1.2 Million | -1.32 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 296.43 Million | 294.3 Million | 285.95 Million | 291.4 Million | 287.94 Million | 284.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 296.43 Million | 294.3 Million | 285.95 Million | 291.4 Million | 287.94 Million | 284.94 Million |
| Gross Margin | 0.43 | 0.47 | 0.50 | 0.48 | 0.54 | 0.57 |
| EBIT Margin | -0.17 | -0.15 | - | -0.11 | -0.58 | -1.06 |
| Profit Margin | -0.09 | -0.09 | -0.29 | -0.17 | -0.45 | -0.92 |
| EBITDA | -852 Thousand | -727 Thousand | - | -496 Thousand | -1.53 Million | -1.52 Million |
| Earnings Before Tax Margin | -0.18 | -0.16 | -0.34 | -0.13 | -0.58 | -1.08 |
MFC
0R3E
AEO
EDRY
TEFOF
BZTAF